Inventor · disambiguated record
Cheng-Der Tony Yu
Also filed as: YU CHENG · YU CHENG D · YU CHENG-DER · YU CHENG-DER TONY
33 granted patents·10 pending applications·3,062 citations·filing 1981–2023
97Inventor score
Files withOBI PHARMA INC21BRISTOL MYERS SQUIBB CO4SYNTEX INC4AT & T BELL LAB3CANYON PHARMACEUTICALS INC2
Top patents by PatentIndex Score
43 records- 0199US4409239APropylene glycol diester solutions of PGE-type compoundsSYNTEX INC·Filed 1982·Granted Oct 11, 1983·614 cites·33 claims
- 0299US4358603AAcetal stabilized prostaglandin compositionsSYNTEX INC·Filed 1981·Granted Nov 9, 1982·287 cites·27 claims
- 0397US5343240ABidirectional video telephony using shared channels on coaxial cable networksAT & T BELL LAB·Filed 1991·Granted Aug 30, 1994·259 cites·44 claims
- 0496US4410545ACarbonate diester solutions of PGE-type compoundsSYNTEX INC·Filed 1982·Granted Oct 18, 1983·609 cites·4 claims
- 0596US4328245ACarbonate diester solutions of PGE-type compoundsSYNTEX INC·Filed 1981·Granted May 4, 1982·613 cites·10 claims
- 0693US5278889AVideo telephony dialingAT & T BELL LAB·Filed 1992·Granted Jan 11, 1994·220 cites·4 claims
- 0791US10815307B2Antibodies, pharmaceutical compositions and uses thereofOBI PHARMA INC·Filed 2017·Granted Oct 27, 2020·5 cites·9 claims
- 0890US11643456B2Human antibodies, pharmaceutical compositions and methodsOBI PHARMA INC·Filed 2017·Granted May 9, 2023·8 cites·32 claims
- 0990US6019988AMethods and compositions for enhancing skin permeation of drugs using permeation enhancers, when drugs and/or permeation enhancers are unstable in combination during long-term storageBRISTOL MYERS SQUIBB CO·Filed 1996·Granted Feb 1, 2000·98 cites·46 claims
- 1090US5219877ALauryl alcohol as skin penetration enhancer for topical imidazole agentsBRISTOL MYERS SQUIBB CO·Filed 1989·Granted Jun 15, 1993·136 cites·22 claims
- 1189US5329308ABidirectional video telephony between cable television and switched telephone systemsAT & T BELL LAB·Filed 1992·Granted Jul 12, 1994·161 cites·27 claims
- 1288US11041017B2Antibodies, pharmaceutical compositions and methodsOBI PHARMA INC·Filed 2017·Granted Jun 22, 2021·4 cites·33 claims
- 1380US11203645B2Glycosynthase variants for glycoprotein engineering and methods of useOBI PHARMA INC·Filed 2019·Granted Dec 21, 2021·3 cites·15 claims
- 1477US11642400B2Immunogenic/therapeutic glycan compositions and uses thereofOBI PHARMA INC·Filed 2017·Granted May 9, 2023·1 cites·11 claims
- 1576US9902779B2Antibodies, pharmaceutical compositions and uses thereofOBI PHARMA INC·Filed 2015·Granted Feb 27, 2018·2 cites·11 claims
- 1672US7795205B2Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumorCANYON PHARMACEUTICALS INC·Filed 2005·Granted Sep 14, 2010·2 cites·13 claims
- 1771US11583577B2Cancer immunotherapy by immune activation or immune modulation via Globo series antigensOBI PHARMA INC·Filed 2017·Granted Feb 21, 2023·1 cites·31 claims
- 1866US11752204B2Vaccines with higher carbohydrate antigen density and novel saponin adjuvantOBI PHARMA INC·Filed 2019·Granted Sep 12, 2023·0 cites·5 claims
- 1965US11833223B2Antibodies, pharmaceutical compositions and methodsOBI PHARMA INC·Filed 2021·Granted Dec 5, 2023·0 cites·9 claims
- 2064US2009269422A1Methods for controlling angiogenesis and cell proliferationYU CHENG-DER TONY·Filed 2009·Application pending·0 cites
- 2162US11236154B2Carbohydrate antibodies, pharmaceutical compositions and uses thereofOBI PHARMA INC·Filed 2019·Granted Feb 1, 2022·0 cites·17 claims
- 2258US10501532B2Carbohydrate antibodies, pharmaceutical compositions and uses thereofOBI PHARMA INC·Filed 2016·Granted Dec 10, 2019·0 cites·4 claims
- 2356US2025137885A1Wear informing system and related methods of useCATERPILLAR INC·Filed 2023·Application pending·0 cites
- 2455US12053514B2Compositions of a carbohydrate vaccine for inducing immune responses and uses thereof in cancer treatmentOBI PHARMA INC·Filed 2014·Granted Aug 6, 2024·0 cites·25 claims
- 2555US10980894B2Antibodies, pharmaceutical compositions and methodsOBI PHARMA INC·Filed 2018·Granted Apr 20, 2021·0 cites·13 claims
- 2655US10517936B2Vaccines with higher carbohydrate antigen density and novel saponin adjuvantOBI PHARMA INC·Filed 2014·Granted Dec 31, 2019·0 cites·16 claims
- 2755US5208015ATopical anti-fungal agents having anti-inflammatory activityBRISTOL MYERS SQUIBB CO·Filed 1991·Granted May 4, 1993·11 cites·11 claims
- 2854US5505715AIontophoretic transdermal delivery of deoxyspergualin compoundsBRISTOL MYERS SQUIBB CO·Filed 1994·Granted Apr 9, 1996·10 cites·27 claims
- 2953US2024139301A1Active cancer immunotherapy by immune modulation via globo series antigensOBI PHARMA INC·Filed 2021·Application pending·0 cites
- 3050US11773118B2Methods of making high enantioselective secondary alcoholsOBI PHARMA INC·Filed 2020·Granted Oct 3, 2023·0 cites·20 claims
- 3148US2025327822A1Companion diagnostic assay for globo-h related cancer therapyLAI MING TAIN·Filed 2020·Application pending·0 cites
- 3248US2021396759A1Method for Predicting Human Immune ResponseOBI PHARMA INC·Filed 2019·Application pending·0 cites
- 3348US2020138967A1Combination therapy using anti-ssea-4 antibody in combination with therapeutic oncology agentsOBI PHARMA INC·Filed 2019·Application pending·0 cites
- 3447US12221461B2Saponin adjuvant and evaluation method thereofOBI PHARMA INC·Filed 2019·Granted Feb 11, 2025·0 cites·15 claims
- 3547US11993541B2Multitype-adsorptive-group polycarboxylic acid water-reducing agent, method for preparing the same and use thereofSOBUTE NEW MAT CO LTD·Filed 2019·Granted May 28, 2024·0 cites·10 claims
- 3647US2004161459A1Fast-dissolve tablet technologyFiled 2003·Application pending·0 cites
- 3745USRE36707EVideo telephony dialingAT & T CORP·Filed 1996·Granted May 23, 2000·18 cites·5 claims
- 3845US2011224150A1Methods for effecting regression of tumor mass and size in a metastasized tumorCANYON PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 3944US8110223B2Methods for making pharmaceutical dosage forms containing active cushioning componentsAUGSBURGER LARRY·Filed 2003·Granted Feb 7, 2012·0 cites·11 claims
- 4042US2019389963A1Combination therapy by using anti-globo h or anti-ssea-4 antibody with anti-negative immune check points antibodyOBI PHARMA INC·Filed 2019·Application pending·0 cites
- 4138US2016339089A1Immunogenic/therapeutic glycoconjugate compositions and uses thereofOBI PHARMA INC·Filed 2015·Application pending·0 cites
- 4230US12440543B2Botulinum toxin type a complex, and formulation thereof and usage method thereforOBIGEN PHARMA INC·Filed 2020·Granted Oct 14, 2025·0 cites·5 claims
- 4327US9259450B2Use of a fermented soy extract as a prebiotic compositionCHUANG MING-HONG·Filed 2011·Granted Feb 16, 2016·0 cites·14 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →